title: Long-term cost-efficacy of rituximab in immune thrombocytopenic purpura.
authors.forename: J I
authors.initials: JI
authors.lastname: Pérez-Calvo
authors.forename: F
authors.initials: F
authors.lastname: Ruiz-Ruiz
authors.forename: B
authors.initials: B
authors.lastname: Amores
authors.forename: M A
authors.initials: MA
authors.lastname: Torralba
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003362:Cost-Benefit Analysis; D006801:Humans; D007155:Immunologic Factors / Q000191:economics / Q000627:therapeutic use*; D008297:Male; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy* / Q000191:economics; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab